The Justice Department announced Monday that the University of California San Diego School of Medicine “unlawfully used race in its admissions process.” Assistant Attorney General Harmeet Dhillon framed the finding as the discovery of a “racial proxy” — a workaround for the Supreme Court’s 2023 ban on race-conscious admissions. The press release landed with the cadence of a verdict. It was not a verdict. It was a letter.
The letter describes what UC San Diego’s admissions officers did, and what the DOJ concluded about it. It does not describe a court order. It does not describe an enforceable ruling. It describes the position of the Civil Rights Division of the United States Department of Justice, transmitted to the University of California, in the early weeks of an administration that announced on Jan. 21, 2025 that it intended to use exactly this apparatus to dismantle race-conscious admissions nationwide. The finding is the opening move in an enforcement campaign the executive branch designed; the predicate for the campaign is the predicate for the finding. To evaluate whether the campaign is producing justice, you have to look at what the campaign is for.
The structural pattern is the same one this column has been tracking since the Civil Rights Division announced fifteen simultaneous medical school investigations on June 4, following its finding against UC Davis one month prior: similar letters landing at UCLA and Yale in May, the same Title VI statutory citation, the same interpretive move that reads the 2023 Harvard/UNC ruling as banning any consideration of race the administration wants to characterize as consideration. The campaign is not investigating specific medical schools for specific conduct. The campaign is establishing the legal infrastructure for a position the administration needs to be true.
Cui Bono: Who Benefits From the Finding
UC San Diego’s admissions data, as reported, showed Black applicants admitted at 5.14% and White applicants admitted at just under 2%. The DOJ’s letter presents this disparity as evidence of discrimination against White and Asian applicants. The first question the cui bono trace asks is the one the press release is engineered to make you forget: what were the applicants’ other qualifications, and how would the school weigh them across the application pool? The answer, which the DOJ’s letter omits, is that the school weighed them as part of a holistic review designed to produce doctors for underserved communities — the very outcome the administration’s own narrative requires it to ignore.
The DOJ’s framing — that “a Black or Hispanic student had a substantially higher likelihood of being admitted than a White or Asian student with the same academic credentials” — concedes, in the word “credentials,” that the question of credentials is part of the analysis. It does not concede what the credentials include. Medical school admissions have always evaluated candidates on far more than MCAT scores and GPA. Clinical experience. Research. Letters of recommendation. The lived experience of having grown up in a community that produces fewer doctors than it needs. The stated intent to practice in an underserved community. The demonstrated commitment to serving patients whose lives resemble the applicant’s own. UC San Diego, like every medical school in the country, has long argued that race is one input among many into the question of who will become the doctor a medically underserved community can actually see.
The Trump administration’s position is that this consideration is illegal. The administration’s Executive Order of Jan. 21, 2025 directed the DOJ and the Department of Education to issue guidance to federally funded institutions on complying with the 2023 ruling. The administration is not interpreting the Supreme Court’s decision. The administration is using the decision as the legal predicate for a position the administration already held. The press release calls the finding “blatant.” The blatancy is the point. The administration needs a finding it can call blatant. A finding that has to be explained in the careful language of administrative procedure does not produce the political product the campaign is built to manufacture.
The Bad-Faith Apparatus at Work
The campaign deploys three documented techniques from the publication’s bad-faith techniques catalog, applied here in the specific form they take when a government actor is the speaker.
The first is the suppressed variable. The press release names “race” as the operative variable in UC San Diego’s admissions process. It does not name the variables the admissions office actually weighs, the historical patterns those variables reflect, or the medical access disparities the school was trying to address. The omission is the work. By isolating race as the variable to be examined, the finding renders the question of why race was being considered — what medical access problem, what physician-diversity problem, what community-health problem the school was responding to — invisible. The variable that would contextualize the finding is the variable the finding suppresses.
The second is goalpost-shifting on the 2023 Supreme Court decision. The Harvard/UNC ruling struck down race-conscious admissions as then practiced at those institutions. It did not, on the textual reading, foreclose every consideration of race in higher education admissions; the majority opinion repeatedly noted the narrowness of its holding. The Trump administration’s interpretive position is that the ruling “bans the use of race in higher education admissions.” That is a stronger claim than the ruling made. The administration is using the decision as authority for a position the decision does not establish. The press release asserts the interpretive move as fact. The goalposts have moved, and the letter is what the movement produced.
The third is coordinated message discipline. The DOJ’s announcement on Monday came one month after the UC Davis finding, after the UCLA finding in May, after the Yale finding, after the June 4 announcement of fifteen simultaneous medical school investigations. The cadence is not the cadence of an enforcement apparatus responding to individual complaints. The cadence is the cadence of a campaign. The Civil Rights Division is not finding things and announcing them. The Civil Rights Division is executing a sequence.
What the Finding Letter Is
The DOJ’s finding is a finding letter. It is the Civil Rights Division’s documented position that UC San Diego’s admissions process violated Title VI and the 2023 Supreme Court ruling. The finding letter is the agency’s stated conclusion; it is not a court order. Whether the letter becomes the predicate for further administrative or judicial action is a question the campaign’s subsequent moves will answer.
The administration does not need a ruling. The administration needs a press release. The press release produces the political product the campaign is built to manufacture: a story in which race-conscious admissions are being dismantled by an enforcement apparatus enforcing the law. The story obscures the structure the column is built to name. The structure is a campaign, executing a sequence, using interpretive moves the underlying decision does not establish, to dismantle programs the administration has long opposed. The campaign is producing what the administration wants. The campaign is producing the campaign.
The recipients of the administration’s enforcement are medical schools that have spent decades arguing, in court filings and admissions policies and faculty governance documents, that the doctor who graduates from their program and returns to the community the applicant came from will provide care that a graduate from outside that community cannot. The DOJ’s letter does not engage that argument. The letter does not need to engage that argument. The letter is not built to engage that argument. The letter is built to produce a press release that does not engage that argument.
The Long Arc
The medical school that graduates a student who returns to a community with no doctors is producing a public good the federal enforcement apparatus is not measuring. The public good has a name in the literature. It is called physician-diversity-driven access to care. The literature has been accumulating for thirty years. The administration has not engaged the literature because engaging the literature would require the administration to defend the dismantling of a program that produces the public good on grounds other than “race was considered.”
King told the Riverside Church audience in April 1967 that the cost of a war was being measured in dollars the budget appropriated, and that the budget was a moral X-ray. The press release the Civil Rights Division issued on Monday is also a moral X-ray. The press release measures what the administration wants to measure. The press release does not measure what the administration is dismantling. The press release does not measure what the dismantled program was producing for the communities the press release is not about. By every structural measure the column applies — cui bono, root cause, the asymmetric leverage frame from Andor (in which a regime’s escalating force signals weakness, not strength) — the campaign the DOJ is running is a campaign that knows the position it wants to be true and is producing the apparatus to enforce the position.
The press release was a letter. The letter was a move in a sequence. The sequence is the campaign. The campaign is the enforcement. The enforcement is the policy. The policy is what the administration wanted. The administration got what it wanted. The press release is how the administration tells you it got what it wanted.
The press release is a press release. The press release is not the law. The press release is not a ruling. The press release is what the administration wants you to read, and nothing more.
Malcolm Little King
Main Street Independent, July 21, 2026